![](https://medcitynews.com/wp-content/uploads/sites/7/2018/09/GettyImages-507157076-600x389.jpg)
![](https://medcitynews.com/wp-content/uploads/sites/7/2022/06/GettyImages-1209662272.jpg)
The Potential for AI in Drug Design
Despite misconceptions about its use, artificial intelligence (AI), through modalities such as machine learning models, is poised to enable companies to expedite the drug design process.
![](https://medcitynews.com/wp-content/uploads/sites/7/2023/12/GettyImages-1366327730.jpg)
Who Should Be Responsible for Rationing GLP-1s?
There is a shortage of GLP-1s in the U.S. But experts have differing opinions on whose responsibility it is to be rationing the drugs.
![](https://medcitynews.com/wp-content/uploads/sites/7/2020/01/GettyImages-869846050.jpg)
Why Is Moon Surgical’s New Commercial Robot System Important?
This month, Moon Surgical received FDA clearance for the commercial version of its Maestro surgical robot system. The system is designed to support surgeons and other operating room staff, specifically for the 18.8 million annual soft tissue surgical procedures not currently supported by available telerobotic systems.
![](https://medcitynews.com/wp-content/uploads/sites/7/2023/03/41241953624_d12c3c8c33_c.jpg)
Avidity Bio’s RNA Therapy Flashes Early Signs of Treating a Muscular Dystrophy’s Root Cause
Avidity Biosciences’ RNA therapy for facioscapulohumeral muscular dystrophy has preliminary clinical data showing it knocked down expression of a gene that causes this rare disease. More details will be presented at a medical conference this week.
![](https://medcitynews.com/wp-content/uploads/sites/7/2021/10/GettyImages-1276702405.jpg)
Reimagining the Language and Translation Space for Patients
Lack of adequate translation and interpreting services isn’t just an inconvenience, it is dangerous and potentially life-threatening.